A Decision-Support Software to Improve the Standard Care in Chinese Type 2 Diabetes
- PMID: 31828162
- PMCID: PMC6881560
- DOI: 10.1155/2019/5491743
A Decision-Support Software to Improve the Standard Care in Chinese Type 2 Diabetes
Abstract
Background: To develop a decision-support software according to the Chinese Diabetes Society guideline in order to improve the standard care in type 2 diabetes.
Methods: Firstly, we developed a decision-support software for healthcare professionals. It was an independent software on a tablet to record the data of patients and treatments given by their physicians. A major function of the software was to remind doctors when and how they should implement the standard care as recommended by the Chinese Diabetes Society guideline. Secondly, we compared the baseline data of standard care including statin and aspirin usage with data from a previous "3B study" to see whether there was an improvement of these standard cares. Finally, we further compared the data during four quarters of the whole year to evaluate whether there was a continuous improvement.
Results: During the first quarter, 27,291 cases and 27,352 cases were collected with complete information about statin and aspirin usage, respectively. The percentage of patients treated with statins and aspirin in our study was significantly higher than that reported in the 3B study (59.6% vs. 19.9% and 59.8% vs. 18.5%, P < 0.001). There were no significant differences among the four quarters for the percentage of the patients who were taking statin or aspirin (P > 0.05).
Conclusion: Our decision-support software has been shown to be effective in continuously improving the standardization of comprehensive treatment in type 2 diabetes.
Copyright © 2019 Yingying Luo et al.
Conflict of interest statement
Linong Ji reported receiving consulting and lecture fees from Eli Lilly, Bristol-Myers Squibb, Novartis, Novo Nordisk, Merck, Bayer, Takeda, Sanofi, Roche, and Boehringer Ingelheim and research grants from Roche and Sanofi. All other authors have no relevant conflicts of interest to disclose.
Figures
References
-
- Right Care. The NHS Atlas of Variation in Healthcare. 2011. http://www.rightcare.nhs.uk.
-
- Adams K., Corrigan J. M., editors. Institute of Medicine (US) Committee on Identifying Priority Areas for Quality Improvement. Priority Areas for National Action: Transforming Health Care Quality. Washington, DC, USA: National Academies Press; 2003. - PubMed
-
- Shojania K. G., KM M. D., Wachter R. M., Owens D. K., editors. AHRQ Technical Reviews. Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol 1: Series Overview and Methodology) Rockville (MD): Agency for Healthcare Research and Quality (US); 2004. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical